Medical News

RSS

AMA calls for fix to Medicare's doctor payments

With a sizable cut to Medicare physician payments taking effect in just one week, the American Medical Association is seeking clarity from Congress on its plan of action to stop the 21.2% reduction.

23 Feb 2010

Access Systems awarded $3.5M contract to support HHS FTS2001-Networx Transition Program Management Office

Access Systems, Inc. (ACCESS), an information technology (IT) solutions provider, has been awarded a $3.5M contract by GSA's National Capital Region to support the Department of Health and Human Services (HHS) FTS2001-Networx Transition Program Management Office. ACCESS and team partner, BCCP Consulting, LLC, will assist HHS to conduct Fair Opportunity for selecting the Networx vendors that will provide telecommunications and associated professional services to the HHS OPDIVs.

23 Feb 2010

Medtronic third-quarter revenues up by 10%

Medtronic, Inc. today reported financial results for the third quarter of fiscal year 2010, which ended January 29, 2010.

23 Feb 2010

NASDAQ halts trading of Salix Pharmaceuticals stock, FDA Committee to discuss XIFAXAN NDA

Salix Pharmaceuticals, Ltd. today announced that NASDAQ has halted trading of the Company’s common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety of the New Drug Application (NDA) for XIFAXAN® (rifaximin) Tablets, 550 mg for the maintenance of remission of hepatic encephalopathy.

23 Feb 2010

Study proves accuracy of MTWA non-invasive test in identifying patients at risk of arrhythmic events and SCD

Cambridge Heart, Inc., today announced that results of a clinical study presented at the 29th Annual Scientific Meeting of the Belgian Society of Cardiology in Brussels, Belgium, reinforce the value of the Microvolt T-wave Alternans (MTWA) as an accurate non-invasive test to identify patients at risk of arrhythmic events and sudden cardiac death (SCD).

23 Feb 2010

Henry Schein announces net sales increase of 13.0% for fourth-quarter 2009

Henry Schein, Inc., the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended December 26, 2009.

23 Feb 2010

Amedisys reports 19.2% increase in fourth-quarter net service revenue

Amedisys, Inc., one of America’s leading home health nursing companies, today reported its financial results for the three months and year ended December 31, 2009. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 19.2% and 43.5%, respectively, over the three month period ended December 31, 2008.

23 Feb 2010

Aradigm initiates dosing in Phase 2b trial of inhaled liposomal ciprofloxacin formulations in BE patients

Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.

23 Feb 2010

Lexicon Pharmaceuticals reports positive results from Phase 2 clinical trials for IBS and type 2 diabetes

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months and year ended December 31, 2009.

23 Feb 2010

Health Canada approves GARDASIL for prevention of genital warts in males

Today, Merck announced that Health Canada has approved GARDASIL(R) (Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Recombinant Vaccine) for boys and men nine through 26 years of age for the prevention of infection caused by HPV types 6, 11, 16, and 18 and genital warts caused by HPV types 6 and 11.

23 Feb 2010

NCC, Pfizer provide over 10M units of ReFacto Antihemophilic Factor to underserved hemophilia patients

The National Cancer Coalition (NCC) is pleased to announce its recent collaboration with Pfizer, Inc to provide hemophilia medicines to underserved patients in the developing world. To date, NCC has received more than 10 million international units of ReFacto® Antihemophilic Factor (Recombinant), a therapy used for the treatment and prevention of bleeding in people with hemophilia A, to assist patients who otherwise would have little opportunity for adequate treatment. The value of this donation is more than $13 million, and it will help many hundreds of hemophilia patients around the world.

23 Feb 2010

Solta Medical announces definitive agreement to acquire Aesthera

Solta Medical, Inc., a global leader in the medical aesthetics market, today announced it has entered into a definitive agreement to acquire privately-held Aesthera Corporation, which is based in Pleasanton, California. Under the terms of the definitive agreement, Solta will acquire Aesthera for $5.25 million in Solta common stock and cash, with potential additional base line milestones of $750,000 for a consideration of $6.0 million. Excluding acquisition and integration related charges, the transaction is expected to be accretive to Solta Medical's earnings within twelve months.

23 Feb 2010

Medco Health Solutions announces record 16.7% increase in total net revenues for 2009

Medco Health Solutions, Inc. today reported record fourth-quarter 2009 GAAP diluted earnings per share of $0.70, up 29.6 percent compared to $0.54 in fourth-quarter 2008. Excluding the amortization of intangible assets that existed when Medco became a publicly traded company in 2003, fourth-quarter 2009 diluted earnings per share increased 28.8 percent to a record $0.76. Medco also reported record full-year 2009 GAAP diluted earnings per share of $2.61, up 22.5 percent -- exceeding the high-end of the company's guidance.

23 Feb 2010

Menssana Research develops 85% accurate breath test for pulmonary tuberculosis

A new breath test can detect active pulmonary tuberculosis, according to a report to be published in the journal "Tuberculosis."

23 Feb 2010

Solta Medical reports revenues of $28.4M for fourth-quarter 2009

Solta Medical, Inc., a global leader in the medical aesthetics market, today announced results for the fourth quarter and full year ended December 31, 2009. Revenue for the fourth quarter was in-line with the preliminary forecast provided on January 8, 2010.

23 Feb 2010

First Edition: February 23, 2010

Today's headlines focus on President Obama's revamped health reform proposal, what it includes and how Democrats, Republicans and the insurers are reacting to it.

23 Feb 2010

Dental checkup before first baby tooth appears may help a lifetime of preventive dental care

Tooth decay is the single most common chronic childhood disease, according to the U.S. Surgeon General. This February, the American Academy of Pediatric Dentistry (AAPD) encourages parents and caregivers to "Get it Done in Year One." Visiting a pediatric dentist by the time the first baby tooth appears enables the child to begin a lifetime of preventive dental care, helping to minimize tooth decay and cavities. In fact, studies show that dental costs for children who have their first dental visit before age one are 40 percent lower in the first five years than for those who do not see a dentist prior to their first birthday.

23 Feb 2010

Connecticut policy makers providing cost effective dental care to children, says report

Connecticut is a national leader in addressing the dental health needs of its children, according to a report released by the Pew Center on the States. The Cost of Delay: State Dental Policies Fail One in Five Children, released with support from the W.K. Kellogg Foundation and the DentaQuest Foundation, grades each state's policy responses to the urgent challenges in dental health among America's children.

23 Feb 2010

Catheter insertion technology patent acquired by Acacia Research subsidiary

Acacia Research Corporation announced today that a subsidiary has acquired patents for catheter insertion technology.

23 Feb 2010

Gross sales of Acorda Therapeutics' ZANAFLEX CAPSULES and tablets increase 9.1% to $58.3M in 2009

Acorda Therapeutics, Inc. today announced its financial results for the fourth quarter and full year ended December 31, 2009.

23 Feb 2010

Medical News

AMA calls for fix to Medicare's doctor payments

Access Systems awarded $3.5M contract to support HHS FTS2001-Networx Transition Program Management Office

Medtronic third-quarter revenues up by 10%

NASDAQ halts trading of Salix Pharmaceuticals stock, FDA Committee to discuss XIFAXAN NDA

Study proves accuracy of MTWA non-invasive test in identifying patients at risk of arrhythmic events and SCD

Henry Schein announces net sales increase of 13.0% for fourth-quarter 2009

Amedisys reports 19.2% increase in fourth-quarter net service revenue

Aradigm initiates dosing in Phase 2b trial of inhaled liposomal ciprofloxacin formulations in BE patients

Lexicon Pharmaceuticals reports positive results from Phase 2 clinical trials for IBS and type 2 diabetes

Health Canada approves GARDASIL for prevention of genital warts in males

NCC, Pfizer provide over 10M units of ReFacto Antihemophilic Factor to underserved hemophilia patients

Solta Medical announces definitive agreement to acquire Aesthera

Medco Health Solutions announces record 16.7% increase in total net revenues for 2009

Menssana Research develops 85% accurate breath test for pulmonary tuberculosis

Solta Medical reports revenues of $28.4M for fourth-quarter 2009

First Edition: February 23, 2010

Dental checkup before first baby tooth appears may help a lifetime of preventive dental care

Connecticut policy makers providing cost effective dental care to children, says report

Catheter insertion technology patent acquired by Acacia Research subsidiary

Gross sales of Acorda Therapeutics' ZANAFLEX CAPSULES and tablets increase 9.1% to $58.3M in 2009

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News